Total Payments
$156.92
2024 Payments
$16.22
Companies
3
Transactions
7
Medicare Patients
3,851
Medicare Billing
$159,057
Payment Breakdown by Category
Food & Beverage$156.92 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $156.92 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Becton, Dickinson and Company | $85.37 | 4 | $0 (2024) |
| Merck Sharp & Dohme LLC | $50.73 | 2 | $0 (2023) |
| Abbott Laboratories | $20.82 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16.22 | 1 | Becton, Dickinson and Company ($16.22) |
| 2023 | $31.70 | 1 | Merck Sharp & Dohme LLC ($31.70) |
| 2022 | $19.03 | 1 | Merck Sharp & Dohme LLC ($19.03) |
| 2021 | $20.82 | 1 | Abbott Laboratories ($20.82) |
| 2020 | $13.67 | 1 | Becton, Dickinson and Company ($13.67) |
| 2019 | $39.66 | 1 | Becton, Dickinson and Company ($39.66) |
| 2017 | $15.82 | 1 | Becton, Dickinson and Company ($15.82) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/27/2024 | Becton, Dickinson and Company | BD MAX System, BD MAX Instrument (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Diagnostic Testing | ||||||
| 03/22/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: ONCOLOGY | ||||||
| 04/27/2021 | Abbott Laboratories | i-STAT 1 (Device) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: Point of Care | ||||||
| 04/27/2020 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $13.67 | General |
| 07/18/2019 | Becton, Dickinson and Company | — | Food and Beverage | In-kind items and services | $39.66 | General |
| 03/30/2017 | Becton, Dickinson and Company | BD SurePath (Device) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Women's Health and Cancer | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,138 | 1,779 | $329,853 | $42,561 |
| 2022 | 15 | 988 | 1,639 | $322,641 | $43,391 |
| 2021 | 14 | 852 | 1,402 | $266,756 | $35,865 |
| 2020 | 14 | 873 | 1,400 | $262,416 | $37,239 |
Total Patients
3,851
Total Services
6,220
Medicare Billing
$159,057
Procedure Codes
62
All Medicare Procedures & Services
62 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 431 | 827 | $193,097 | $20,268 | 10.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 70 | 87 | $32,625 | $3,819 | 11.7% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2023 | 36 | 50 | $17,975 | $2,868 | 16.0% |
| 87624 | Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | Office | 2023 | 79 | 80 | $10,800 | $2,751 | 25.5% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2023 | 188 | 310 | $19,766 | $2,667 | 13.5% |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | Office | 2023 | 74 | 74 | $9,916 | $1,921 | 19.4% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2023 | 12 | 12 | $2,995 | $1,605 | 53.6% |
| G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | Office | 2023 | 74 | 74 | $5,772 | $1,593 | 27.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 26 | 68 | $10,191 | $1,445 | 14.2% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 37 | 44 | $6,192 | $1,140 | 18.4% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2023 | 14 | 36 | $6,272 | $1,131 | 18.0% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 20 | 23 | $4,689 | $456.94 | 9.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 16 | 21 | $1,838 | $399.80 | 21.8% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2023 | 27 | 37 | $5,809 | $286.21 | 4.9% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2023 | 15 | 17 | $1,071 | $148.98 | 13.9% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2023 | 19 | 19 | $845.50 | $60.12 | 7.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 380 | 744 | $172,608 | $19,176 | 11.1% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 44 | 89 | $31,996 | $5,213 | 16.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 76 | 104 | $39,000 | $4,243 | 10.9% |
| G0416 | Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | Facility | 2022 | 24 | 24 | $5,800 | $2,806 | 48.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2022 | 141 | 238 | $14,875 | $2,046 | 13.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 20 | 59 | $10,170 | $1,734 | 17.1% |
| 87624 | Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | Office | 2022 | 48 | 48 | $6,480 | $1,664 | 25.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 25 | 85 | $11,868 | $1,630 | 13.7% |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | Office | 2022 | 45 | 45 | $6,030 | $1,178 | 19.5% |
About Dr. Mark Orton, MD
Dr. Mark Orton, MD is a Clinical Pathology/Laboratory Medicine healthcare provider based in Ogden, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326090465.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Orton, MD has received a total of $156.92 in payments from pharmaceutical and medical device companies, with $16.22 received in 2024. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($156.92).
As a Medicare-enrolled provider, Orton has provided services to 3,851 Medicare beneficiaries, totaling 6,220 services with total Medicare billing of $159,057. Data is available for 4 years (2020–2023), covering 62 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Pathology/Laboratory Medicine
- Other Specialties Anatomic Pathology & Clinical Pathology
- Location Ogden, UT
- Active Since 05/17/2006
- Last Updated 04/03/2020
- Taxonomy Code 207ZP0105X
- Entity Type Individual
- NPI Number 1326090465
Products in Payments
- KEYTRUDA (Biological) $50.73
- i-STAT 1 (Device) $20.82
- BD MAX System, BD MAX Instrument (Device) $16.22
- BD SurePath (Device) $15.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.